AVITA Medical, Inc. filed a current report on November 2, 2026, disclosing that Perceptive Credit Holdings V, LP exercised a warrant for up to 500,000 shares of AVITA common stock through a cashless transaction completed on October 28, 2026.

Key Highlights

  • Warrant exercised: Perceptive Credit Holdings V, LP exercised the warrant on October 26, 2026, via a cashless exercise.
  • Shares withheld: AVITA Medical withheld 112,284 shares to cover the exercise price under the cashless mechanism.
  • Shares issued: 387,716 shares of AVITA common stock were issued to Perceptive on October 28, 2026.
  • Warrant origin: The warrant was issued to Perceptive on June 5, 2026, pursuant to a Credit Agreement and Guaranty dated January 13, 2026.
  • ASX filing: AVITA lodged corresponding disclosures on the Australian Securities Exchange on November 2, 2026, pursuant to ASX listing rules.
  • Exchange listing: AVITA Medical common stock trades on NASDAQ:RCEL with a par value of $0.0001 per share.

AVITA Medical Discloses Cashless Warrant Settlement with Perceptive

According to the filing, AVITA Medical, Inc., a Delaware-incorporated medical company headquartered in Valencia, California, disclosed the exercise of a warrant previously issued to Perceptive Credit Holdings V, LP. The warrant, which was exercisable for up to 500,000 shares of AVITA common stock, had been issued on June 5, 2026, in connection with a Credit Agreement and Guaranty between the company and Perceptive dated January 13, 2026.

The filing states that Perceptive elected a cashless exercise on October 26, 2026. Under this structure, the company withheld 112,284 of the shares covered by the warrant in respect of the exercise price, and issued the remaining 387,716 shares to Perceptive on October 28, 2026. No cash proceeds to the company from this exercise were disclosed in the filing.

AVITA Medical reported that it simultaneously lodged related disclosures on the Australian Securities Exchange on November 2, 2026, in compliance with ASX listing rules, reflecting the company's dual-listed status. The current report was signed by David O'Toole, Chief Financial Officer of AVITA Medical, Inc., on November 2, 2026, under Item 7.01, Regulation FD Disclosure.

What Was Disclosed

AVITA Medical disclosed the cashless exercise of a warrant held by Perceptive Credit Holdings V, LP, resulting in 387,716 shares issued and 112,284 shares withheld for the exercise price, with parallel filings made on the Australian Securities Exchange on November 2, 2026.